MS
Mark Schoenberg sold $400K of URGN stock
Mark Schoenberg, Chief Medical Officer of UroGen Pharma Ltd. (URGN), sold 10,000 shares of URGN stock worth $400K, per an SEC Form 4 filed Jul 10, 2026.
The sale was pre-arranged (a 10b5-1 plan or an option exercise), not a fresh decision.
The trade happened on Jul 9, 2026, 1 day before it was made public.
URGN has moved -31.3% since the trade date, from $40.23 to $27.65 (Nov 20, 2026 close).
- Traded
- Jul 9, 2026
- Disclosed
- Jul 10, 2026
- Filing delay
- 1 day
- Price since
- -31.3%
- Role
- Chief Medical Officer
- Source
- SEC Form 4